Aehr Test Systems (AEHR)
(Delayed Data from NSDQ)
$14.68 USD
-0.06 (-0.41%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $14.64 -0.04 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for Aehr Test Systems falls in the month of May.
All items in Millions except Per Share data.
5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 49 | 48 | 31 | 5 | 5 |
Receivables | 10 | 17 | 13 | 5 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 37 | 24 | 15 | 9 | 8 |
Other Current Assets | 1 | 1 | 1 | 1 | 1 |
Total Current Assets | 98 | 89 | 60 | 19 | 18 |
Net Property & Equipment | 3 | 3 | 1 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 21 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 128 | 98 | 62 | 22 | 21 |
Liabilities & Shareholders Equity | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 1 | 0 |
Accounts Payable | 5 | 9 | 4 | 3 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 2 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 4 | 4 | 2 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 3 | 2 | 0 | 0 |
Total Current Liabilities | 11 | 16 | 11 | 9 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 1 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 16 | 23 | 11 | 10 | 7 |
Shareholders Equity | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 131 | 128 | 118 | 88 | 86 |
Retained Earnings | -19 | -52 | -67 | -76 | -74 |
Other Equity | 0 | 0 | 0 | 0 | 2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 112 | 76 | 51 | 11 | 14 |
Total Liabilities & Shareholder's Equity | 128 | 98 | 62 | 22 | 21 |
Total Common Equity | 112 | 76 | 51 | 11 | 14 |
Shares Outstanding | 28.90 | 28.30 | 26.90 | 23.60 | 23.00 |
Book Value Per Share | 3.86 | 2.67 | 1.90 | 0.49 | 0.61 |
Fiscal Year End for Aehr Test Systems falls in the month of May.
All items in Millions except Per Share data.
5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 49 | 48 | 51 | 51 | 48 |
Receivables | 10 | 5 | 5 | 13 | 17 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 37 | 38 | 34 | 32 | 24 |
Other Current Assets | 1 | 1 | 3 | 1 | 1 |
Total Current Assets | 98 | 92 | 92 | 96 | 89 |
Net Property & Equipment | 3 | 3 | 3 | 3 | 3 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 21 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 128 | 102 | 101 | 105 | 98 |
Liabilities & Shareholders Equity | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 5 | 4 | 8 | 9 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 3 | 3 | 5 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 0 | 0 | 6 | 3 |
Total Current Liabilities | 11 | 9 | 8 | 19 | 16 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 16 | 15 | 14 | 25 | 23 |
Shareholders Equity | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 131 | 129 | 129 | 128 | 128 |
Retained Earnings | -19 | -43 | -42 | -48 | -52 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 112 | 87 | 87 | 80 | 76 |
Total Liabilities & Shareholder's Equity | 128 | 102 | 101 | 105 | 98 |
Total Common Equity | 112 | 87 | 87 | 80 | 76 |
Shares Outstanding | 28.90 | 28.80 | 28.80 | 28.70 | 28.30 |
Book Value Per Share | 3.86 | 3.00 | 3.03 | 2.79 | 2.67 |